By clicking on "Subscribe" you accept our privacy policy.



Краткий обзор презентации:

Доступ к лечению, оптимизация и мониторинг со стороны сообщества в России

Организации гражданского общества в течение многих лет вовлечены в мониторинг закупок и поставок лекарств в России, Восточной Европе и Центральной Азии с помощью ряда механизмов, включая подготовку ежегодных отчетов на основе открытых данных и веб-сайтов для отслеживания дефицита и перебоев с лекарствами. Такая система мониторинга помогла выявить потенциальные направления для улучшения программ лечения ВИЧ-инфекции в странах ВЕЦА, включая выбор лекарств, систему поставок, использование комбинированных препаратов, завышение цен на запатентованные лекарства и т. д. В этой презентации мы обсудим некоторые из этих направлений.

Speaker biography:

Sergey Golovin has worked in the field of healthcare and treatment access for around 10 years, specialising in monitoring availability and prices of essential medicines and linking IP issues with the treatment access agenda. Currently, Sergey is employed as Intellectual Property and Access Lead at the Treatment Preparedness Coalition in Eastern Europe and Central Asia, supervising a variety of research and advocacy projects with a focus on ways to improve treatment access using the resources of community organisations.

Sergey Golovin has been a co-author of a number of articles and reports dedicated to treatment access issues, including a series of reports on HCV and HIV drug procurement in Russia, report on the community response to the HCV Epidemic in EECA, article about safety and efficacy of generic products imported for personal use etc. He has also participated in several global community advisory board meetings and delivered numerous trainings in the field of treatment access for community activists across the globe. Sergey was part of the Global TB-CAB for two years and was involved in a number of projects related to access to TB drugs (including community advisory group meetings and drug procurement monitoring). He is currently a member of the Expert Advisory Group of the Medicines Patent Pool and the WHO HIV Treatment Reference Group for Eastern Europe and Central Asia.


Registration is open

Second Announcement

Take a look

Call for abstracts

Submissions are closed